A Phase 1 Ascending Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Twice Daily Administration of AX-8 Tablets in Healthy Volunteers in a Single-Centre
Latest Information Update: 17 Sep 2021
At a glance
- Drugs AX-8 (Primary)
- Indications Cough
- Focus Adverse reactions
- Sponsors Axalbion
- 06 Jan 2020 Planned End Date changed from 23 Oct 2019 to 28 Feb 2020.
- 06 Jan 2020 Planned primary completion date changed from 23 Oct 2019 to 28 Feb 2020.
- 04 Oct 2019 New trial record